Understanding how natural killer cells respond to HIV
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
This study is looking at how special immune cells called natural killer (NK) cells can remember and fight HIV, with the hope of finding new ways to improve treatments and prevention for people living with the virus.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10893985 on NIH RePORTER |
What this research studies
This research investigates the role of natural killer (NK) cells in responding to HIV infection. It focuses on how these cells can develop memory and specific responses to the virus, which may enhance their ability to fight HIV. The study involves examining the mechanisms behind NK cell activation and their potential to provide a robust immune response against HIV. By analyzing both human and non-human primate models, the research aims to uncover new strategies for harnessing NK cells in HIV treatment and prevention.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are interested in new treatment approaches that leverage their immune system.
Not a fit: Patients who are not infected with HIV or those who have advanced AIDS may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that enhance the immune response against HIV, potentially improving outcomes for patients living with the virus.
How similar studies have performed: Previous studies have shown promise in utilizing NK cells for antiviral responses, indicating that this approach may lead to significant advancements in HIV treatment.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Reeves, Roger Keith — Duke University
- Study coordinator: Reeves, Roger Keith
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.